2023 Financial Outlook
Full year 2023 guidance is as follows:
- Sales of $760 million to $790 million1
- Sales of $145 million to $155 million for proportionate 50% share of Zeolyst Joint Venture, which is excluded from GAAP Sales
- Adjusted EBITDA2 of $285 million to $300 million, up 6% from 2022 at the mid-point of the range, and inclusive of impacts from Winter Storm Elliott
- Adjusted Free Cash Flow2 of $115 million to $130 million
- Capital expenditures of $60 million to $70 million
- Interest expense of $45 million to $50 million
- Depreciation & Amortization
- Ecovyst – $80 million to $90 million
- Zeolyst J.V. – $14 million to $16 million
1Sales outlook for 2023 assumes lower average sulfur prices, compared to 2022, and lower projected pass-through of sulfur costs of approximately $95 million.
